期刊论文详细信息
Virology Journal
Susceptibility and lack of evidence for a viremic state of rabies in the night owl monkey, Aotus nancymaae
Joel M Montgomery1  David E Bentzel1  Thomas J Steinbach2  Tadeusz J Kochel1  Carolina Guevara1  Gabriela Salmón-Mulanovich1  Erik J Reaves1 
[1] Naval Medical Research Unit No. 6, Av. Venezuela cdra. 36 s/n, Callao 2, Peru;Walter Reed Army Institute of Research, 503 Robert Grant Av, Silver Spring, MD, 20910-7500, USA
关键词: Vaccine;    Ante mortem;    Non-human Primate;    Aotus nancymaae;    Monkey;    Viremia;    Incubation period;    Lyssavirus;    Rhabdovirus;    Rabies;   
Others  :  1154655
DOI  :  10.1186/1743-422X-9-95
 received in 2011-09-14, accepted in 2012-04-24,  发布年份 2012
PDF
【 摘 要 】

Background

Rabies causes an acute fatal encephalomyelitis in most mammals following infection with rhabdovirus of the genus Lyssavirus. Little is known about rabies virus infection in species of New World non-human Primates (NHP). To investigate the suitability of the owl monkey Aotus nancymaae asissue sections examined were unremarkable for inflammation or other histologic signs of rabies a viable animal model for rabies virus candidate vaccine testing, we used clinical presentation, serology, viral isolation, and PCR to evaluate the incubation period, immunity, and pathogenesis of infected animals. We tested the hypothesis that no viremic state exists for rabies virus.

Methods

Eight monkeys divided into two equal groups were inoculated intramuscularly either in the neck or footpad with 105 pfu of rabies virus (Pasteur/V-13R) and observed for >130 days. Oral and blood samples were collected and analyzed.

Results

Two monkeys inoculated in the neck displayed classic paralytic rabies. The mean incubation period was 11.5 days. The average maximum IgG response (antibody titer >0.200 O.D.) was achieved at day 10.0 and 62.3 in the clinical rabies and non-clinical rabies cases, respectively (p = 0.0429). No difference in IgM or IgG time to seroconversion or average maximum IgM level was observed between neck versus footpad inoculation groups. No viremia or viral shedding was detected by PCR or viral isolation during the observation period, including within the two symptomatic animals three days after disease onset. Tissue sections examined were unremarkable for inflammation or other histologic signs of rabies within the asymptomatic animal. Similarly none of the brain sections exhibited immunoreactivity for rabies virus antibody.

Discussion

This study demonstrates there is no difference in time to immune response between inoculation sites and distance to the brain; however, immune response tends to be more rapid in cases of clinically apparent disease and prolonged in cases infected at sites further from the brain.

Conclusions

Our findings support the hypothesis that a viremic state for rabies does not exist in the New World Monkey, Aotus nancymaae, and it appears that this species may be refractory to infection. The species does provide a suitable model to assess post infection immune responses. Additional studies that address the limitations of sample size, length of observation, and lack of measurable infection should be conducted.

【 授权许可】

   
2012 Reaves et al.;The article is a work of the United States Government; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150407105652743.pdf 754KB PDF download
Figure 4. 48KB Image download
Figure 3. 46KB Image download
Figure 2. 45KB Image download
Figure 1. 43KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】
  • [1]WHO, W: Expert Consultation on Rabies. WHO Technical Report Series: first report; 2005:931.
  • [2]Duenas A, et al.: Isolation of rabies virus outside the human central nervous system. J Infect Dis 1973, 127(6):702-704.
  • [3]Jackson AC: Rabies virus infection: an update. J Neurovirol 2003, 9(2):253-258.
  • [4]Belotto A, et al.: Overview of rabies in the Americas. Virus Res 2005, 111(1):5-12.
  • [5]Favi M, et al.: First case of human rabies in chile caused by an insectivorous bat virus variant. Emerg Infect Dis 2002, 8(1):79-81.
  • [6]Gomez-Benavides J, et al.: Outbreak of human rabies in Madre de Dios and Puno, Peru due to contact with the common vampire bat, Desmodus rotundus. AmJTrop Med Hyg 2007, 77(5_Suppl):150-199.
  • [7]Salmón-Mulanovich G, et al.: Human rabies and rabies in vampire and nonvampire, southeastern Peru, 2007. Emerg Infect Dis 2009, 15(8):3.
  • [8]Schneider MC, et al.: Rabies transmitted by vampire bats to humans: an emerging zoonotic disease in Latin America? Rev Panam Salud Publica 2009, 25(3):260-269.
  • [9]Suzan G, et al.: Modeling hantavirus reservoir species dominance in high seroprevalence areas on the azuero peninsula of panama. AmJTrop Med Hyg 2006, 74(6):1103-1110.
  • [10]Andrade MC, et al.: Immune response produced by anti-rabies vaccines in marmosets(Callithrix sp). Rev Soc Bras Med Trop 1999, 32(5):533-540.
  • [11]Favoretto SR, et al.: Rabies virus maintained by dogs in humans and terrestrial wildlife, Ceara State, Brazil. Emerg Infect Dis 2006, 12(12):1978-1981.
  • [12]Favoretto SR, et al.: Rabies in marmosets (Callithrix jacchus), Ceara, Brazil. Emerg Infect Dis 2001, 7(6):1062-1065.
  • [13]INS: Informe Especial. In La Rabia en el Perú 2004–2006. Edited by Vargas Herrera J. Lima: Instituto Nacional de Salud; 2006:33.
  • [14]NASPHV: Compendium of Animal Rabies Prevention and Control, 2011. Atlanta: Morbidity and Mortality Weekly Report (MMWR); 2011:1-14. 60
  • [15]Kenny DE, et al.: Exposure of hooded capuchin monkeys (Cebus apella cay) to a rabid bat at a zoological park. J Zoo Wildl Med 2001, 32(1):123-126.
  • [16]Jones FR, et al.: The New World primate, Aotus nancymae, as a model for examining the immunogenicity of a prototype enterotoxigenic Escherichia coli subunit vaccine. Vaccine 2006, 24(18):3786-3792.
  • [17]Constantine DG: Absence of prenatal infection of bats with rabies virus. J Wildl Dis 1986, 22(2):249-250.
  • [18]Sitprija V, et al.: Does contact with urine and blood from a rabid dog represent a rabies risk? Clin Infect Dis 2003, 37(10):1399-1400.
  • [19]Burne JC: Viraemia in rabies. Lancet 1970, 1(7639):195-196.
  • [20]Lodmell DL, Dimcheff DE, Ewalt LC: Viral RNA in the bloodstream suggests viremia occurs in clinically ill rabies-infected mice. Virus Res 2006, 116(1–2):114-118.
  • [21]Sims RA, Allen R, Sulkin SE: Studies on the pathogenesis of rabies in insectivorous bats. III. Influence of the gravid state. J Infect Dis 1963, 112:17-27.
  • [22]Baratawidjaja RK, Morrissey LP, Labzoffsky NA: Demonstration of vaccinia, lymphocytic choriomeningitis and rabies viruses in the leucocytes of experimentally infected animals. Arch Gesamte Virusforsch 1965, 17(2):273-279.
  • [23]Crepin P, et al.: Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid. J Clin Microbiol 1998, 36(4):1117-1121.
  • [24]Smith J, et al.: Case report: rapid ante-mortem diagnosis of a human case of rabies imported into the UK from the Philippines. J Med Virol 2003, 69(1):150-155.
  • [25]Nagaraj T, et al.: Ante mortem diagnosis of human rabies using saliva samples: comparison of real time and conventional RT-PCR techniques. J Clin Virol 2006, 36(1):17-23.
  • [26]Hughes GJ, et al.: Evaluation of a TaqMan PCR assay to detect rabies virus RNA: influence of sequence variation and application to quantification of viral loads. J Clin Microbiol 2004, 42(1):299-306.
  • [27]Charlton KM, Casey GA, Campbell JB: Experimental rabies in skunks: immune response and salivary gland infection. Comp Immunol Microbiol Infect Dis 1987, 10(3–4):227-235.
  • [28]Charlton KM, Casey GA, Campbell JB: Experimental rabies in skunks: mechanisms of infection of the salivary glands. Can J Comp Med 1983, 47(3):363-369.
  • [29]Oliveira AN, et al.: Immune response in cattle vaccinated against rabies. Mem Inst Oswaldo Cruz 2000, 95(1):83-88.
  • [30]Hooper DC, et al.: Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol 1998, 72(5):3711-3719.
  • [31]Irwin DJ, et al.: Basis of rabies virus neurovirulence in mice: expression of major histocompatibility complex class I and class II mRNAs. J Neurovirol 1999, 5(5):485-494.
  • [32]Warrell MJ, Warrell DA: Rabies and other lyssavirus diseases. Lancet 2004, 363(9413):959-969.
  • [33]Schuller E, et al.: IgM and IgG antibody responses in rabies encephalitis. Ann Microbiol (Paris) 1979, 130A(3):365-372.
  • [34]Passos EC, et al.: Inactivated suckling mouse brain rabies vaccine provides short-term immunity in capuchin monkeys (Cebus apella). J Zoo Wildl Med 2001, 32(1):55-57.
  • [35]Baer GM: The natural history of rabies1991. Boston: CRC; 1991.
  • [36]Johnson N, Cunningham AF, Fooks AR: The immune response to rabies virus infection and vaccination. Vaccine 2010, 28(23):3896-3901.
  • [37]East ML, et al.: Regular exposure to rabies virus and lack of symptomatic disease in Serengeti spotted hyenas. Proc Natl Acad Sci U S A 2001, 98(26):15026-15031.
  • [38]Council NR: Guide for the Care and Use of Laboratory Animals1996. Washington, D.C: National Academy Press; 1996:125.
  文献评价指标  
  下载次数:39次 浏览次数:4次